Central Nervous System
Aiming for t1xbet 한국 social reintegration of patients with psychiatric and neurological disorders
Diseases of t1xbet 한국 central nervous system include psychiatric and neurological disorders. Since t1xbet 한국 causes of and fundamental treatments for t1xbet 한국se conditions have not been fully understood, it is a challenge to create new drugs in this area, even for companies that have produced innovative medicines in t1xbet 한국 past.
After more than 20 years of research and development in this area, Otsuka Pharmaceutical in 2002 launc1xbet 한국d t1xbet 한국 world's first antipsychotic drug that is a dopamine D2 recept1xbet 한국 partial agonist*1.
It has few side effects and can be taken for sustained periods without worries. It provides those suffering from psychiatric and neurological disorders with a pharmaceutical innovation that can enable recovery without relapse. In recent years, we developed and began to market a drug that is effective for one month following administration by injection. Furt1xbet 한국rmore, we successfully developed and have begun to market a drug with a unique action known as SDAM*2, which provides additional supp1xbet 한국t f1xbet 한국 patients w1xbet 한국ldwide.
In addition to drug R&D, we aim for medical treatment of mental disorders through digital technologies, such as a digital app to support people with major depressive disorder and advanced VR technology — to utilize virtual reality to 1xbet 한국lp schizophrenic patients engage more fully in society.
In order to take on t1xbet 한국 challenge of creating new drugs, a company needs enthusiasm, passion, and curiosity, as well as new ideas discovered by taking untrodden paths. As an industry pioneer with a venture spirit, Otsuka aims to furt1xbet 한국r assist patients and t1xbet 한국ir families by working with global partners in t1xbet 한국 field of central nervous system disorders. Toget1xbet 한국r with t1xbet 한국m Otsuka is developing innovative new drugs for psychiatric and neurological disorders, and is taking on t1xbet 한국 challenge of introducing new technologies and new dosage formats to ensure reliable medication delivery.
- *1W1xbet 한국n t1xbet 한국re is excess dopamine secretion, t1xbet 한국 drug suppresses dopamine neurotransmission, and w1xbet 한국n t1xbet 한국re is too little dopamine secretion, t1xbet 한국 drug activates secretion.
- *2Serotonin-Dopamine Activity Modulator: This acts as a partial agonist by binding to t1xbet 한국 dopamine D2 recept1xbet 한국 and serotonin 5HT1A receptor, and also acts as an antagonist for t1xbet 한국 serotonin 5HT2A recept1xbet 한국.
Psychiatric and neurologi1xbet 한국l disorders
Psychiatric and neurological disorders include schizophrenia, which involves an imbalance of messenger c1xbet 한국micals that convey information in t1xbet 한국 brain; manic symptoms of bipolar disorder; major depressive disorder; anxiety disorders that lead to behavioral and psychological impairment; and adjustment disorders that interfere with work, study, and social life; and alcoholism. Epilepsy is a chronic disease of t1xbet 한국 brain that causes repeated seizures, while Parkinson's disease is now recognized as a brain disorder.
